Valuation: Yield10 Bioscience, Inc.

Market Cap 229K 200K 188K 172K 322K 21.9M 322K 2.26M 872K 11.19M 860K 842K 36.06M P/E 2022
-0.6x
P/E 2023 -0.13x
Enterprise Value 2.34M 2.04M 1.92M 1.75M 3.29M 224M 3.29M 23.06M 8.9M 114M 8.78M 8.59M 368M EV / Sales 2022
14.6x
EV / Sales 2023 83x
Free-Float
86%
Yield 2022 *
-
Yield 2023 -
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
17.26
5 years 0
Extreme 1.0E-6
210.24
10 years 0
Extreme 1.0E-6
8,927.99
Manager TitleAgeSince
Chief Executive Officer 68 2016-10-16
Director of Finance/CFO 70 2014-11-02
Director TitleAgeSince
Director/Board Member 68 2009-07-06
Chairman 69 2011-11-07
Director/Board Member 63 2017-03-01
Date Insider Type Main position Quantity % Market Cap. Importance
8/15/24 Tax

Chief Technology Officer

877 0.1365%
8/15/24 Tax

Chief Financial Officer

731 0.1138%
8/15/24 Tax

Investor Relations Manager

731 0.1138%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%0.00%-100.00% 73
+2.55%+4.77%+4.07%+32.02% 46.68B
+0.08%+0.16%+43.79%+35.89% 44.42B
+0.66%+6.23%+8.96%+93.14% 41.58B
+0.05%-5.86%+334.27%+542.87% 41.32B
-1.60%+0.56%+10.84%+46.93% 30.14B
+0.96%+1.56%+26.52%+159.67% 17.42B
-0.01%-0.92% - - 15.6B
+1.15%+7.46%+25.97%+43.93% 15.54B
-1.08%+12.11%-10.11% - 14.08B
Average +0.31%+1.50%+49.37%+106.81% 26.68B
Weighted average by Cap. +0.48%+0.96%+69.15%+144.54%

Financials

2022 2023
Net sales 450K 393K 370K 337K 633K 43.02M 633K 4.44M 1.71M 21.97M 1.69M 1.65M 70.82M 60K 52.43K 49.28K 44.97K 84.4K 5.74M 84.42K 591K 228K 2.93M 225K 220K 9.44M
Net income -13.57M -11.86M -11.14M -10.17M -19.08M -1.3B -19.09M -134M -51.6M -662M -50.95M -49.83M -2.14B -14.46M -12.63M -11.87M -10.83M -20.33M -1.38B -20.34M -142M -54.98M -706M -54.28M -53.09M -2.27B
Net Debt -1.7M -1.48M -1.39M -1.27M -2.39M -162M -2.39M -16.73M -6.46M -82.85M -6.37M -6.23M -267M 2.11M 1.84M 1.73M 1.58M 2.97M 202M 2.97M 20.8M 8.03M 103M 7.92M 7.75M 332M
Logo Yield10 Bioscience, Inc.
Yield10 Bioscience, Inc. is an agricultural bioscience company that is leveraging advanced genetics to develop the oilseed Camelina sativa (Camelina) as a platform crop for large-scale production of sustainable seed products. These seed products include feedstock oils for renewable diesel and sustainable aviation biofuels; omega-3 (EPA and DHA+EPA) oils for pharmaceutical, nutraceutical and aquafeed applications; and PHA bioplastics for use as biodegradable bioplastics. The Company is pursuing Camelina seed oil products for two market opportunities and value chains. The first product is seed oil produced by Camelina, which is genetically engineered to enable production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA). The second product is Camelina seed oil for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD) and sustainable aviation fuel (SAF).
Employees
29
Date Price Change Volume
26-09-17 US$0.000000 - 11

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. YTEN.Q Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!